0001347383-26-000003.txt : 20260603 0001347383-26-000003.hdr.sgml : 20260603 20260603200306 ACCESSION NUMBER: 0001347383-26-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260602 FILED AS OF DATE: 20260603 DATE AS OF CHANGE: 20260603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen David E CENTRAL INDEX KEY: 0001347383 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42938 FILM NUMBER: 261062818 MAIL ADDRESS: STREET 1: 3160 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evommune, Inc. CENTRAL INDEX KEY: 0002044725 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 850742575 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1891 PAGE MILL RD CITY: PALO ALTO STATE: CA BUSINESS PHONE: (650) 223-7745 MAIL ADDRESS: STREET 1: 1891 PAGE MILL RD CITY: PALO ALTO STATE: CA 4 1 primarydocument.xml PRIMARY DOCUMENT X0609 4 2026-06-02 false 0002044725 Evommune, Inc. EVMN 0001347383 Cohen David E false C/O EVOMMUNE, INC. 1891 PAGE MILL ROAD PALO ALTO CA 94304 true false false false true Common Stock 2026-06-02 4 S false 5456.00 20.21 D 18209.00 D Common Stock 2026-06-02 4 S false 600.00 21.38 D 17609.00 D Stock Option (Right to buy) 19.82 2026-06-02 4 A false 15673.00 0.00 A 2036-06-01 Common Stock 15673.00 15673.00 D The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $20.00 to $20.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $21.06 to $21.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. The shares subject to the option award shall vest at the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through such vesting date. /s/ Gregory S. Moss, Attorney-in-Fact 2026-06-03